Organisation profile
Organisation profile
We establishes a cross-disciplinary doctoral degree with equal emphasis on foundation and application, focuses on the development of the institute's smart medical profession, and cooperates with the Research Center of Big Data, Taipei Medical University to cultivate more professionals who are capable of engaging in international biomedical management research; The other top ten colleges in Taipei Medical University form a cross-disciplinary research cooperation team to build the research and development talents of this degree.
In order to comply with the trend of internationalization, this degree program will be taught in English, actively attracting international students, and actively recruiting internationally renowned scholars to teach and research together. On the one hand, it enhances professional energy and promotes more international cooperation and increases international competitiveness.
We actively expand the smart application of biotechnology and medical management, introduce a system of practitioners, and form a direct link with the industry. Students are expected to translate their knowledge into applied knowledge, add value to the industry and produce positive and direct influences.
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
Chiao-Chen Chang
- Executive Master Program of Business Administration in Biotechnology (EMBA) - Associate Professor
- International Ph.D. Program in Biotech and Healthcare Management - Joint-Appointment Associate Professor
Person: Researcher
-
Wei Pin Chang
- School of Health Care Administration - Professor
- International Ph.D. Program in Biotech and Healthcare Management - Joint-Appointment Professor
- TMU Research Center of Artificial Intelligence in Medicine and Health - Member
Person: Researcher
-
Yao-Mao Chang
- School of Health Care Administration - Associate Professor
- Department of Education and Humanities in Medicine - Joint Appointment Associate Professor
- International Ph.D. Program in Biotech and Healthcare Management - Joint-Appointment Associate Professor
- Executive Master Program of Business Administration in Biotechnology (EMBA) - Joint-Appointment Associate Professor
- TMU Research Center of Health and Welfare Policy - Member
Person: Researcher
-
Personalized Risk Evaluation and Clinical Insights in Cardiovascular-Kidney-Metabolic Syndrome (Precise-Ckm Project)
Hsu, J. C. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
建立糖尿腎病病患之心血管相關風險的預測模型
Hsu, J. C. (PI)
7/1/25 → 2/28/26
Project: A - Government Institution › b - National Science and Technology Council
-
傳染病科技實證支援防疫決策之COVID-19疫情量能估算模式研究
Hsu, J. C. (PI)
1/1/25 → 12/31/25
Project: A - Government Institution › c - Ministry of Health and Welfare
Research output
-
Cardiovascular Risk and Prediction Model of Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors in Patients with Liver Cancer
Chen, Y. C., Huang, C. Y., Lien, L. M., Chen, J. H., Bintoro, B. S. & Hsieh, F. I., Mar 2026, In: Cardiovascular Toxicology. 26, 3, 29.Research output: Contribution to journal › Article › peer-review
-
Concurrent Chinese and Western medication use and risk of acute exacerbations in chronic obstructive pulmonary disease: A national cohort study
Lee, M. C., Wu, C. Y., Chen, S. M., Chang, Y. H., Peng, T. R., Chen, J. H., Satake, S., Lee, J. A., Lee, C. H. & Wang, J. Y., Jun 2026, In: Integrative Medicine Research. 15, 2, p. 101286 101286.Research output: Contribution to journal › Article › peer-review
Open Access -
Effectiveness comparison of nirmatrelvir/ritonavir versus molnupiravir in COVID-19 patients with comorbidities in Taiwan: a multi-centre electronic health record study
Lin, W. K., Lin, S. J., Chang, Y. H., Wang, F. D., Nguyen, P. A., Phuc, P. T., Burton, W., Hien, N. T. K., Lin, C. C., Lam, C. S. K., Ha, T. C., Lu, C. Y., Huang, C. W., Yang, H. C., Lin, S. M., Yang, C., Wang, L. H. & Hsu, J. C., Dec 2026, In: BMC Infectious Diseases. 26, 1, 70.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Additional file 1 of Health inequality: a longitudinal study on geographic variations in lung cancer incidence and mortality in Taiwan
Hsu, J. C. (Contributor), Tseng, Y.-C. (Contributor), Chang, S.-M. (Contributor), Lee, Y.-C. (Contributor), Lin, P.-C. (Contributor) & Chu, H.-J. (Contributor), Unknown Publisher, Jun 17 2020
DOI: 10.6084/m9.figshare.12503261.v1, https://springernature.figshare.com/articles/Additional_file_1_of_Health_inequality_a_longitudinal_study_on_geographic_variations_in_lung_cancer_incidence_and_mortality_in_Taiwan/12503261/1
Dataset
-
Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis
Chang, Y.-H. (Creator), Li, W.-H. (Contributor), Chang, Y. (Creator), Peng, C.-W. (Creator), Cheng, C.-H. (Contributor), Chang, W.-P. (Creator) & Chuang, C.-M. (Contributor), Figshare, 2016
DOI: 10.6084/m9.figshare.c.3642380.v1, https://figshare.com/collections/Front-line_intraperitoneal_versus_intravenous_chemotherapy_in_stage_III-IV_epithelial_ovarian_tubal_and_peritoneal_cancer_with_minimal_residual_disease_a_competing_risk_analysis/3642380/1
Dataset
-
Additional file 5 of Isotypes of autoantibodies against novel differential 4-hydroxy-2-nonenal-modified peptide adducts in serum is associated with rheumatoid arthritis in Taiwanese women
Tsai, K.-L. (Contributor), Chang, C.-C. (Creator), Chang, Y.-S. (Creator), Lu, Y.-Y. (Creator), Tsai, I.-J. (Contributor), Chen, J.-H. (Creator), Lin, S.-H. (Creator), Tai, C.-C. (Contributor), Lin, Y.-F. (Creator), Chang, H.-W. (Creator), Lin, C.-Y. (Creator) & Su, E.C.-Y. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.13889400.v1, https://springernature.figshare.com/articles/dataset/Additional_file_5_of_Isotypes_of_autoantibodies_against_novel_differential_4-hydroxy-2-nonenal-modified_peptide_adducts_in_serum_is_associated_with_rheumatoid_arthritis_in_Taiwanese_women/13889400/1
Dataset